Clinical pharmacist participated in the drug treatment practice of a patient with ulcerative colitis accompanied by facial aseptic abscesses
10.12173/j.issn.1005-0698.202412049
- VernacularTitle:1例溃疡性结肠炎伴发面部无菌性脓肿患者的药物治疗与监护
- Author:
Liping WU
1
;
Peipei ZHANG
;
Naizhong HU
;
Yanyan WANG
Author Information
1. 铜陵市立医院药学部(安徽铜陵 244000)
- Publication Type:Journal Article
- Keywords:
Ulcerative colitis;
Aseptic abscess;
Parenteral manifestation;
Infliximab;
Pharmaceutical care
- From:
Chinese Journal of Pharmacoepidemiology
2025;34(9):1094-1098
- CountryChina
- Language:Chinese
-
Abstract:
The clinical pharmacist was involved in the whole process of drug treatment and monitoring of a patient with ulcerative colitis(UC)and facial aseptic abscesses.After admission,clinical pharmacists and physicians jointly formulated an empirical anti-infection plan for meropenem and linezolid glucose injection.After the 5th day of medication,the patient continued to have high fever.After discussion with the physician and clinical pharmacist,it was considered that the patient's facial boil was caused by aseptic abscess syndrome,and UC with extraintestinal manifestations could not be ruled out.Hydrocortisone succinate sodium was added intravenously.After the 9th day of treatment,the patient's facial abscesses improved.Subsequently,the physician followed the clinical pharmacist's advice and used infliximab as the subsequent treatment plan.After the 11th day of treatment,the patient's symptoms improved significantly.During the 2-month follow-up,the facial abscesses completely disappeared,the stool was normal,and there were no special discomforts.The participation of clinical pharmacists in clinical practice improves patients' understanding of the disease and treatment compliance,providing patients with individualized medication support to ensure the safety and effectiveness of medication.
